Literature DB >> 12640119

Transcription-dependent degradation of topoisomerase I-DNA covalent complexes.

Shyamal D Desai1, Hui Zhang, Alexandra Rodriguez-Bauman, Jin-Ming Yang, Xiaohua Wu, Murugesan K Gounder, Eric H Rubin, Leroy F Liu.   

Abstract

Topoisomerase I (Top I)-DNA covalent complexes represent a unique type of DNA lesion whose repair and processing remain unclear. In this study, we show that Top I-DNA covalent complexes transiently arrest RNA transcription in normal nontransformed cells. Arrest of RNA transcription is coupled to activation of proteasomal degradation of Top I and the large subunit of RNA polymerase II. Recovery of transcription occurs gradually and depends on both proteasomal degradation of Top I and functional transcription-coupled repair (TCR). These results suggest that arrest of the RNA polymerase elongation complex by the Top I-DNA covalent complex triggers a 26S proteasome-mediated signaling pathway(s) leading to degradation of both Top I and the large subunit of RNA polymerase II. We propose that proteasomal degradation of Top I and RNA polymerase II precedes repair of the exposed single-strand breaks by TCR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12640119      PMCID: PMC150741          DOI: 10.1128/MCB.23.7.2341-2350.2003

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  38 in total

Review 1.  Tumor cell death induced by topoisomerase-targeting drugs.

Authors:  T K Li; L F Liu
Journal:  Annu Rev Pharmacol Toxicol       Date:  2001       Impact factor: 13.820

2.  Benzo[a]pyrene diol epoxide adducts in DNA are potent suppressors of a normal topoisomerase I cleavage site and powerful inducers of other topoisomerase I cleavages.

Authors:  Y Pommier; G Kohlhagen; P Pourquier; J M Sayer; H Kroth; D M Jerina
Journal:  Proc Natl Acad Sci U S A       Date:  2000-02-29       Impact factor: 11.205

3.  ICE bioassay. Isolating in vivo complexes of enzyme to DNA.

Authors:  D Subramanian; C S Furbee; M T Muller
Journal:  Methods Mol Biol       Date:  2001

4.  26 S proteasome-mediated degradation of topoisomerase II cleavable complexes.

Authors:  Y Mao; S D Desai; C Y Ting; J Hwang; L F Liu
Journal:  J Biol Chem       Date:  2001-08-23       Impact factor: 5.157

5.  The topoisomerase I-binding RING protein, topors, is associated with promyelocytic leukemia nuclear bodies.

Authors:  Zeshaan A Rasheed; Ahamed Saleem; Yaniv Ravee; Pier Paolo Pandolfi; Eric H Rubin
Journal:  Exp Cell Res       Date:  2002-07-15       Impact factor: 3.905

6.  Ultraviolet-induced DNA damage stimulates topoisomerase I-DNA complex formation in vivo: possible relationship with DNA repair.

Authors:  D Subramanian; B S Rosenstein; M T Muller
Journal:  Cancer Res       Date:  1998-03-01       Impact factor: 12.701

7.  Ubiquitin/26S proteasome-mediated degradation of topoisomerase I as a resistance mechanism to camptothecin in tumor cells.

Authors:  S D Desai; T K Li; A Rodriguez-Bauman; E H Rubin; L F Liu
Journal:  Cancer Res       Date:  2001-08-01       Impact factor: 12.701

8.  Pathways for repair of topoisomerase I covalent complexes in Saccharomyces cerevisiae.

Authors:  J J Pouliot; C A Robertson; H A Nash
Journal:  Genes Cells       Date:  2001-08       Impact factor: 1.891

9.  A Rad26-Def1 complex coordinates repair and RNA pol II proteolysis in response to DNA damage.

Authors:  Elies C Woudstra; Chris Gilbert; Jane Fellows; Lars Jansen; Jaap Brouwer; Hediye Erdjument-Bromage; Paul Tempst; Jesper Q Svejstrup
Journal:  Nature       Date:  2002-02-21       Impact factor: 49.962

10.  Mutation of TDP1, encoding a topoisomerase I-dependent DNA damage repair enzyme, in spinocerebellar ataxia with axonal neuropathy.

Authors:  Hiroshi Takashima; Cornelius F Boerkoel; Joy John; Gulam Mustafa Saifi; Mustafa A M Salih; Dawna Armstrong; Yuxin Mao; Florante A Quiocho; Benjamin B Roa; Masanori Nakagawa; David W Stockton; James R Lupski
Journal:  Nat Genet       Date:  2002-09-16       Impact factor: 38.330

View more
  56 in total

1.  p53 stimulates human topoisomerase I activity by modulating its DNA binding.

Authors:  Kent Søe; Frank Grosse
Journal:  Nucleic Acids Res       Date:  2003-11-15       Impact factor: 16.971

2.  Genome-wide analysis of novel splice variants induced by topoisomerase I poisoning shows preferential occurrence in genes encoding splicing factors.

Authors:  Stéphanie Solier; Jennifer Barb; Barry R Zeeberg; Sudhir Varma; Mike C Ryan; Kurt W Kohn; John N Weinstein; Peter J Munson; Yves Pommier
Journal:  Cancer Res       Date:  2010-09-03       Impact factor: 12.701

Review 3.  Human DNA topoisomerase I: relaxation, roles, and damage control.

Authors:  John B Leppard; James J Champoux
Journal:  Chromosoma       Date:  2005-04-14       Impact factor: 4.316

Review 4.  Repair of topoisomerase I-mediated DNA damage.

Authors:  Yves Pommier; Juana M Barcelo; V Ashutosh Rao; Olivier Sordet; Andrew G Jobson; Laurent Thibaut; Ze-Hong Miao; Jennifer A Seiler; Hongliang Zhang; Christophe Marchand; Keli Agama; John L Nitiss; Christophe Redon
Journal:  Prog Nucleic Acid Res Mol Biol       Date:  2006

Review 5.  Targeting Topoisomerase I in the Era of Precision Medicine.

Authors:  Anish Thomas; Yves Pommier
Journal:  Clin Cancer Res       Date:  2019-06-21       Impact factor: 12.531

Review 6.  The applications of the novel polymeric fluoropyrimidine F10 in cancer treatment: current evidence.

Authors:  William H Gmeiner; Waldemar Debinski; Carol Milligan; David Caudell; Timothy S Pardee
Journal:  Future Oncol       Date:  2016-06-09       Impact factor: 3.404

Review 7.  SUMO modification of DNA topoisomerase II: trying to get a CENse of it all.

Authors:  Ming-Ta Lee; Jeff Bachant
Journal:  DNA Repair (Amst)       Date:  2009-02-20

8.  ISG15 as a novel tumor biomarker for drug sensitivity.

Authors:  Shyamal D Desai; Laurence M Wood; Yu-Chen Tsai; Tao-Shih Hsieh; Jeffrey R Marks; Georgia L Scott; Beppino C Giovanella; Leroy F Liu
Journal:  Mol Cancer Ther       Date:  2008-06       Impact factor: 6.261

9.  Proteasome inhibition suppresses DNA-dependent protein kinase activation caused by camptothecin.

Authors:  Ryo Sakasai; Hirobumi Teraoka; Randal S Tibbetts
Journal:  DNA Repair (Amst)       Date:  2009-12-03

10.  Transcription blockage by bulky end termini at single-strand breaks in the DNA template: differential effects of 5' and 3' adducts.

Authors:  Alexander J Neil; Boris P Belotserkovskii; Philip C Hanawalt
Journal:  Biochemistry       Date:  2012-10-24       Impact factor: 3.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.